(19)
(11) EP 2 866 870 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.12.2021 Bulletin 2021/51

(45) Mention of the grant of the patent:
17.11.2021 Bulletin 2021/46

(21) Application number: 13828380.9

(22) Date of filing: 08.08.2013
(51) International Patent Classification (IPC): 
A61M 16/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 16/06; A61M 2205/0216; A61M 16/0605; A61M 16/0683
(86) International application number:
PCT/NZ2013/000139
(87) International publication number:
WO 2014/025267 (13.02.2014 Gazette 2014/07)

(54)

MASK AND HEADGEAR SYSTEM

MASKEN- UND KOPFHAUBESYSTEM

SYSTÈME À MASQUE ET HARNAIS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 08.08.2012 US 201261681024 P

(43) Date of publication of application:
06.05.2015 Bulletin 2015/19

(60) Divisional application:
21202022.6

(73) Proprietor: Fisher & Paykel Healthcare Limited
East Tamaki, Auckland 2013 (NZ)

(72) Inventors:
  • MCLAREN, Mark Arvind
    Auckland 2013 (NZ)
  • HAMMER, Jeroen
    Auckland 2013 (NZ)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)


(56) References cited: : 
EP-A1- 1 902 743
EP-A2- 2 327 443
WO-A1-2004/041342
WO-A1-2012/045127
WO-A1-2014/020469
WO-A2-2014/175752
US-A1- 2006 174 892
US-A1- 2007 215 161
US-B1- 6 338 342
 EP-A2- 0 350 322
WO-A1-97/32494
WO-A1-2009/052560
WO-A1-2012/143822
WO-A1-2014/175753
US-A1- 2006 118 119
US-A1- 2007 215 161
US-A1- 2009 183 739
   
  • None
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).